I empathise with the long term holders, but IMO the director spent too much on market a couple of days ago for this to be in danger of imminent demise, unless he was a complete fool.
Enough cash for the FY and a couple of promising projects, with Hep B now slightly ahead of last provided time line, so I am happy to hold and may average down if it drops some more.
